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Objective: There is renewed scientific interest in the potential of plant-derived agents 
for the treatment of diabetes mellitus. This study investigated the antidiabetic actions 
of Swertia chirayita, a plant used traditionally in the management of diabetes.  
 
Methods: Insulin secretion from BRIN-DB11 cells was assessed in the absence or 
presence of plant extract and modulators of beta cell function. Glucose uptake was 
assessed using 3T3-L1 cells while effects of the plant extract on protein glycation was 
assessed using model peptide. Insulin was measured by radioimmunoassay and 




Results: Swertia chirayita stimulated concentration-dependent insulin secretion from 
BRIN-BD11 cells (P<0.001). Its insulinotropic effects were abolished in the absence 
of extracellular Ca
2+  
or by diazoxide (P<0.001, n=8) and were significantly decreased 
by verapamil and in beta cell depolarization by with KCl. Swertia chirayita extracts 
evoked a 28 – 59% increase in basal and insulin-stimulated glucose uptake by 3T3-L1 
cells. Protein glycation was significantly (P<0.05 – P<0.001) inhibited by S. chirayita 
in a dose-dependent manner.   
 
Conclusion: This study reveals that the antidiabetic actions of S. chirayita aqueous 
bark extracts involves the stimulation of insulin secretion and enhancement of insulin 
action. Inhibition of protein glycation may also help counter diabetic complications. 




Diabetes mellitus is a major health problem, which is emerging as a pandemic 
contemporaneous with changes in lifestyle and longer life-expectancy [1].  Treatment 
of diabetes is advancing on a number of fronts, ranging from better understanding of 
the mechanisms of action of existing agents to the development of new drugs [2].  
Regimens currently employed include lifestyle modification, oral-antidiabetic drugs 
and more widespread use of insulin therapy.  Despite their usefulness, none of these 
treatments either alone or/in combination can mimic physiological insulin release or 
prevent the development of chronic complications [3].  Nature is an exemplary source 
of medications and indigenous remedies have been used in the treatment of diabetes 
mellitus in many parts of the world since the 6
th
 century BC [4].  Use of traditional 
medicines in the treatment of diabetes mellitus is probably based primarily on 
alleviation of its obvious symptoms such as pronounced thirst and polyuria.  Recently, 
there has been a renaissance of clinical, pharmaceutical and scientific interest in the 
potential of plant treatments.  However out of an estimated 250,000 higher plants, it is 
estimated that less than 1% has been screened pharmacologically [5,6].  
  
Swertia chirayita is a medicinal plant indigenous to temperate Himalaya and its 
medicinal usage has been reviewed previously [7].  It is widely esteemed in 
Ayurvedic medicine and also used as bitter tonic in treatment of fever and various 
skin diseases [7].  An increasing body of evidence also support the use of this herb in 
the treatment of diabetes [8].  Swerchirin (1:8 dihyroxy 3:5 dimethoxy xanthones), 
derived from the hexane fraction of Swertia chirayita, has demonstrated anti-
hyperglycaemic activity in fasted, fed, glucose-loaded, tolbutamide pre-treated and 
STZ-induced diabetic rats [9-11].  However, mechanisms by which Swertia chirayita 
ameliorates hyperglycaemia are not fully understood. The present study investigated 
the effects of aqueous extracts of Swertia chirayita bark on insulin secretion and 
glucose uptake at the cellular level and assessed its effects on protein glycation in 
vitro.  
 
Materials and Methods 
Plant material 
Dried bark of Swertia chirayita was obtained from a commercial supplier, Cure Herbs 
PVt, Delhi, India. A voucher specimen of the plant is available. Bark was 
homogenised to a fine powder and stored in opaque screw-top jars at room 
temperature (20 ºC  2
 o 
C) until use.  For in vitro studies, an aqueous decoction was 
prepared by bringing 25 g/L of material to the boil in distilled water.  Once boiling, 
the suspension was removed from the heat and allowed to infuse over 15 minutes.  
The suspension was filtered (Whatman no.1 filter paper) and the volume adjusted so 
the final concentration was 25 g/L. 1 mL aliquots of the filtered plant solution were 
brought to dryness under vacuum (Savant Speedvac, Savant Instrumentation Incorp., 
NY, USA).  Dried fractions were stored at –20 ºC until required.  Fractions were 
reconstituted in incubation buffer for subsequent experiments as required. 
 
Insulin secretion 
Insulin release was determined using monolayers of BRIN BD11 clonal pancreatic 
cells [12].  BRIN-BD11 cells were grown in RPMI-1640 tissue culture medium 
containing 11.1 mmol glucose/L, 10% fetal calf serum and antibiotics (50,000 IU 
penicillin-streptomycin/L), and maintained at 37 ºC in an atmosphere of 5% CO2 and 
95% air.  Cells were harvested and seeded in 24 - well plates at a density of 1.0 x 10
5
 
cells per well.  Following overnight attachment, culture medium was removed and 
cells were pre-incubated for 40 min at 37 ºC with 1 mL of Krebs Ringer bicarbonate 
(KRB) buffer (115 mM NaCl, 4.7 mM KCl, 1.28 mM CaCl2, 1.2 mM KH2PO4, 1.2 
mM MgSO4, 10 mM NaHCO3 and 0.1 % (w/v) bovine serum albumin, pH 7.4) 
supplemented with 1.1 mM glucose. Subsequent test incubations were performed for 
20 min at 5.6 mM glucose using similar buffer containing aqueous plant extract and 
the agents indicated in Figures.  Samples were stored at –20 ºC for insulin 
radioimmunoassay [13].  Cell viability was assessed using a modified neutral red 





 Effects of aqueous extracts of Swertia chirayita and other stimuli on intracellular 
calcium concentration ([Ca
2+
]i) in BRIN-BD11 cells were determined fluorometrically 
as previously described [15-16] using FLIPR [Ca
2+
]i (Molecular Devices, Sunnyvale, 
CA, USA) according to the manufacturer’s protocol. Data were captured using a 
FlexStation scanning fluorometer with integrated fluid transfer workstation 
(Molecular Devices).  
 
Adipocyte differentiation and cellular glucose uptake 
Effects of extracts of Swertia chirayita on cellular glucose uptake were assessed using 
3T3-L1 fibroblasts (American Type Culture Collection, ATCC, Virginia, USA) as 
previously described [16, 17]. Briefly, cells were seeded in 12-well plates at a density 
of 1.0 x 10
5
 cells per well, maintained at 37ºC ± 2 ºC with 5% CO2 and grown in 
DMEM culture medium supplemented with penicillin (50 U/mL), streptomycin (50 
l/mL) and fetal bovine serum (10 % v/v). Culture medium was changed every 48 h.    
Adipocyte differentiation was initiated by the addition of 1 g/mL insulin, 0.5 mM 
IBMX and 0.25 M dexamethosone (Mathews et al., 2006).  Differentiated cells were 
incubated in serum free DMEM for 2 h to establish basal glucose uptake prior to acute 
  
test.  Cellular glucose uptake was determined for 15 min at 37ºC using KRB buffer 
supplemented with tritiated 2-deoxyglucose (0.5 Ci/well), glucose (50 mM), insulin 
and other test agents as indicated in the Figures.    
 
Protein glycation 
 Effects of aqueous extracts of Swertia chirayita on in vitro protein glycation was 
assessed using insulin as a model substrate as previously described [16, 18]. Human 
insulin (1 mg/ml, 100 l) was incubated for 24 h in sodium phosphate buffer (10 mM, 
pH 7.4) containing sodium cyanoborohydride (1.35 mM dissolved in 10mM NaOH) 
and  D-glucose (220 mM) in the presence or absence of graded concentrations of plant 
extract. The reaction was stopped by addition of acetic acid (0.5 M).  Glycated and 
non-glycated insulin were separated and quantified using reversed-phase high 
performance liquid chromatography [18].   
  
Statistical analysis 
All results are expressed as mean  SEM for a given number of observations (n).  
Groups of data were compared statistically using one-way ANOVA followed by 
Newman-Keul post hoc comparison for data sets with p<0.05. 
RESULTS 
Insulin secretion studies 
Insulin-release from BRIN BD11 cells, following incubation with  aqueous extract of 
Swertia chirayita at 5.6mM glucose, increased significantly in a dose-dependent 
manner at concentrations ≥ 0.01 mg/ml) (Figure 1A) without affecting cell viability 
(Figure 1B). Insulin secretion was also augmented by Swertia chirayita extracts 1.1 
mM) and 16.7mM glucose (P<0.001, n=8, Figure 2). Stimulation of insulin secretion 
by Swertia chirayita (0.5 mg/ml) were completely abolished in the presence of 
diazoxide (300M) and diminished in the presence of verapamil (50µM, Figure 2).  
Furthermore, the extract produced a significant 2-fold increase (P<0.001) in insulin 
secretion in the presence of IBMX and its effects were significantly (P<0.001) 
augmented in the presence of 200M tolbutamide (Figure 2).   However, the extract 
did not significantly increase insulin secretion in cells depolarised with 30 mM KCl 





Swertia chirayita plant extract (1mg/ml) induced a sharp rise followed by a sustained 
increase in [Ca
2+
]i (Figure 4A).  Addition of verapamil (50M) resulted in a marked 
and sustained reduction in the sharp rise of [Ca
2+
]i (Figure 4B).  
 
 
Glucose uptake in vitro 
Swertia chirayita (1mg/ml) produced a 28% increase in glucose uptake compared to 
unsupplemented control (p<0.01, Figure 5).  Glucose uptake increased by 59% when 
insulin was combined with the plant extract compared with effects observed in the 
presence of insulin alone (Figure 5).  
 
Protein glycation in vitro 
Aqueous extract of Swertia chirayita produced a dose-dependent inhibition of insulin 
glycation. The lowest inhibition of 8% was observed at the extract concentration of 
1mg/ml while a maximum inhibition of 25% was observed in the presence of 





Scientific studies providing evidence for therapeutic efficacies of many plant 
materials used in ethno-medicinal practices are increasing [16, 19]. In the case of 
Swertia chirayita, pharmacological actions such as antipyretic, analgesic, anthelminitic 
and antiperiodic effects have been reported [20]. Studies reporting hypoglycaemic and 
antidiabetic effects of various extracts of the plant are also increasing. For instance, 
Kar et al [19] reported that ethanolic extracts of Swertia chirayita significantly 
lowered blood glucose in rats with alloxan-induced diabetic rats. In addition, several 
studies have implicated swerchirin (3,5-Dimethoxy-1,8-dihydroxyxanthone) isolated 
from the plant as responsible for its hypoglycaemic effects [21-23]. In agreement with 
these reports, our present study showed that aqueous extract of Swertia chirayita, 
stimulated insulin secretion in a concentration-dependent manner from BRIN BD11 
cells without affecting cell viability.   
 
Though reports of the actual mechanism of hypoglycaemic actions of extracts of 
Swertia chirayita or swerchirin are generally absent, the observed lack of cellular 
cytotoxicity observed in the present study indicates that the insulinotropic effect of the 
plant extract was not due to simple leakage of insulin from the cells. Moreover, 
inhibition of the insulinotropic activity in the absence of extracellular calcium or with 
diazoxide strongly suggests the involvement Ca
2+
 influx and the KATP-dependent 
pathway in the stimulatory actions of the plant extract [16, 24-25]. Indeed, exposure 
of BRIN-BD11 cells to Swertia chirayita produced a substantial rise of intracellular 
calcium concentration [Ca
2+
]i which was attenuated but not completely abolished by 
the calcium channel blocker, verapamil. The ability of extract to enhance the 
insulinotropic actions of tolbutamide further supports involvement of the voltage 
dependent calcium channels (VDCC) and KATP-channels. This ability of 
sulphonylureas to augment the action of Swertia chirayita has been reported in a 
number of other studies [9, 26].  
 
In addition to its prominent beta cell stimulatory effects, aqueous extract of Swertia 
chirayita enhanced basal cellular glucose transport in differentiated 3T3-L1 
adipocytes.  The stimulatory action of insulin (10
-9 
M) was also augmented in the 
presence of 1mg/ml of extract.  The combined actions of the extract and insulin were 
greater than the effects of either agent alone. Such observations are consistent with 
previous studies by Saxena et al. [10] which demonstrated increased glucose uptake 
and glycogen synthesis in diaphragm muscle in rats administered with S. chirayita 
extracts. Furthermore, the additive effect of Swertia chirayita on glucose uptake may 
suggest actions outside the normal insulin-signalling pathway.   Further studies are 
needed to assess the possible novelty of the mechanisms involved. 
In the final series of experiments, Swertia chirayita extract was shown to 
inhibit protein glycation using insulin as a model substrate [18]. Interestingly, aqueous 
and ethanolic extracts of Swertia chirayita have been reported to contain a number of 
potent antioxidants such as xanthones, glycosides, triterpenoids [29] and magniferin 
[30], which acts at different levels of the oxidation sequence [31].  Thus, the 
antiglycation actions apparent in the present investigation may be due to its high 
antioxidant content. This finding also presupposes that treatment with S. chirayita 
may be beneficial in preventing the onset diabetic complications.  
 
In conclusion, the current investigation corroborates earlier reports of the antidiabetic 
actions Swertia chirayita [9-11]. In addition, this study has shown that extract of 
aqueous bark extract of Swertia chirayita stimulated both the secretion and action of 
insulin as well as inhibited protein glycation. The ability of plant constituents to 
influence these parameters in vivo depends entirely on soluble active principle(s) 
being absorbed via the gut and will form the focus of our future studies.   
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Legends to Figures: 
 
Figure 1: Dose-dependent effects of Swertia chirayita (A) on insulin secretion and beta cell 
viability (B) in BRIN BD11 cells.  Values are mean ± SEM of 8 separate observations.  
***P<0.001 compared to the control. 
 
Figure 2: Modulation of Swertia chirayita extract-induced insulin secretion by 
established stimulators and inhibitors of beta cell function.  Values are mean ± SEM 
of 8 separate observations.  **P<0.01, ***P<0.001 compared to compared to 5.6 mM 
glucose. 
+++





to the respective incubations in absence of plant extract.  
 
Figure 3:  Effects of extracellular calcium on insulin release stimulated by Swertia 
chirayita.  Values are mean ± SEM of 8 separate observations.  ***P<0.001compared 




P<0.001 compared to the respective 









Figure 4. Effects of Swertia chirayita on intracellular Ca
2+
 in the absence (A) and 
presence of verapamil (B).  Values are mean ± SEM of 6 separate observations. 
 
Figure 5: Effects of Swertia chirayita extracts on 2-deoxy-D-[H
3
]-glucose transport. 
Results are mean  SEM of 4 separate observations. **P<0.01, ***P<0.001 compared 
with incubations in the absence of insulin. 
+++
P<0.001 compared to 10
-9
 M insulin 
alone. 
 
P<0.001 compared to Swertia chirayita incubations without insulin.  
 
Figure 6: Effects of Swertia chirayita extract on protein glycation. Results are mean ± 
SEM of 3 separate observations. **P<0.01, ***P<0.001 compared to glycation in the 














































































































































































5.6 mM G +
Verapamil
(50 µM)
5.6 mM G +
Diazoxide
(300 µM)
16.7 mM G +
KCl
(30 mM)
16.7 mM G +
IBMX
(100 µM)
5.6 mM G +
Tolbutamide
(200 µM)
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